372 related articles for article (PubMed ID: 16866578)
41. Progress towards tuberculosis elimination in Cuba.
González E; Armas L; Llanes MJ
Int J Tuberc Lung Dis; 2007 Apr; 11(4):405-11. PubMed ID: 17394686
[TBL] [Abstract][Full Text] [Related]
42. Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.
Huynh GH; Klein DJ; Chin DP; Wagner BG; Eckhoff PA; Liu R; Wang L
BMC Med; 2015 Apr; 13():88. PubMed ID: 25896465
[TBL] [Abstract][Full Text] [Related]
43. The Styblo model 20 years later: what holds true?
Arnadottir T
Int J Tuberc Lung Dis; 2009 Jun; 13(6):672-90. PubMed ID: 19460242
[TBL] [Abstract][Full Text] [Related]
44. Scientific basis of directly observed treatment, short-course (DOTS).
Sharma SK; Mohan A
J Indian Med Assoc; 2003 Mar; 101(3):157-8, 166. PubMed ID: 14603962
[TBL] [Abstract][Full Text] [Related]
45. Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.
Yew WW
Kekkaku; 2011 Jan; 86(1):9-16. PubMed ID: 21401001
[TBL] [Abstract][Full Text] [Related]
46. CDC Grand Rounds: the TB/HIV syndemic.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jul; 61(26):484-9. PubMed ID: 22763886
[TBL] [Abstract][Full Text] [Related]
47. Prospects for new tuberculosis treatment in Africa.
Mwinga A; Bernard Fourie P
Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
[TBL] [Abstract][Full Text] [Related]
48. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach.
Mandal S; Bhatia V; Sharma M; Mandal PP; Arinaminpathy N
BMC Med; 2020 Jul; 18(1):163. PubMed ID: 32684164
[TBL] [Abstract][Full Text] [Related]
49. Tuberculosis drug discovery and emerging targets.
Mdluli K; Kaneko T; Upton A
Ann N Y Acad Sci; 2014 Sep; 1323():56-75. PubMed ID: 24920100
[TBL] [Abstract][Full Text] [Related]
50. The Global TB Drug Facility: innovative global procurement.
Kumaresan J; Smith I; Arnold V; Evans P
Int J Tuberc Lung Dis; 2004 Jan; 8(1):130-8. PubMed ID: 14974756
[TBL] [Abstract][Full Text] [Related]
51. Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.
Harries AD; Hargreaves NJ; Chimzizi R; Salaniponi FM
Bull World Health Organ; 2002; 80(6):464-9. PubMed ID: 12132003
[TBL] [Abstract][Full Text] [Related]
52. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
53. Shorter antibiotic regimens impact the control efforts in high tuberculosis burden regions of Taiwan.
Lin YJ; Lin HC; Yang YF; Chen CY; Lu TH; Liao CM
Int J Infect Dis; 2020 Aug; 97():135-142. PubMed ID: 32474203
[TBL] [Abstract][Full Text] [Related]
54. Rapid DOTS expansion in India.
Khatri GR; Frieden TR
Bull World Health Organ; 2002; 80(6):457-63. PubMed ID: 12132002
[TBL] [Abstract][Full Text] [Related]
55. Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach.
Han WM; Mahikul W; Pouplin T; Lawpoolsri S; White LJ; Pan-Ngum W
PLoS One; 2021; 16(3):e0248846. PubMed ID: 33770104
[TBL] [Abstract][Full Text] [Related]
56. Treatment of tuberculosis infection in children.
Hatzenbuehler LA; Starke JR
Expert Rev Anti Infect Ther; 2018 Sep; 16(9):695-708. PubMed ID: 30132364
[TBL] [Abstract][Full Text] [Related]
57. Rapid assessment of facilitators and barriers related to the acceptance, challenges and community perception of daily regimen for treating tuberculosis in India.
Negandhi H; Tiwari R; Sharma A; Nair R; Zodpey S; Reddy Allam R; Oruganti G
Glob Health Action; 2017; 10(1):1290315. PubMed ID: 28485693
[TBL] [Abstract][Full Text] [Related]
58. Tuberculosis-a World Health Organization Perspective.
Sotgiu G; Sulis G; Matteelli A
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185618
[TBL] [Abstract][Full Text] [Related]
59. The tuberculosis profile of the Philippines, 2003-2011: advancing DOTS and beyond.
Vianzon R; Garfin AM; Lagos A; Belen R
Western Pac Surveill Response J; 2013; 4(2):11-6. PubMed ID: 24015366
[TBL] [Abstract][Full Text] [Related]
60. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.
Trauer JM; Denholm JT; McBryde ES
J Theor Biol; 2014 Oct; 358():74-84. PubMed ID: 24878110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
